CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 279 filers reported holding CONMED CORP in Q1 2022. The put-call ratio across all filers is 3.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,534,361 | +704.6% | 25,130 | +1085.9% | 0.06% | +326.7% |
| Q1 2022 | $315,000 | +38.2% | 2,119 | +27.6% | 0.02% | -21.1% |
| Q2 2021 | $228,000 | -58.8% | 1,661 | -66.4% | 0.02% | -67.8% |
| Q4 2020 | $554,000 | +0.5% | 4,942 | -35.4% | 0.06% | +55.3% |
| Q2 2020 | $551,000 | -56.8% | 7,647 | -65.7% | 0.04% | -59.1% |
| Q1 2020 | $1,276,000 | +129.9% | 22,280 | +349.0% | 0.09% | +181.8% |
| Q4 2019 | $555,000 | -2.8% | 4,962 | -27.7% | 0.03% | -19.5% |
| Q1 2019 | $571,000 | +149.3% | 6,860 | +137.4% | 0.04% | +141.2% |
| Q3 2018 | $229,000 | -41.0% | 2,890 | -62.0% | 0.02% | -60.5% |
| Q4 2017 | $388,000 | -48.3% | 7,610 | -55.0% | 0.04% | -55.2% |
| Q1 2017 | $751,000 | +147.9% | 16,900 | +134.3% | 0.10% | +166.7% |
| Q1 2016 | $303,000 | -27.5% | 7,213 | -24.1% | 0.04% | -2.7% |
| Q4 2015 | $418,000 | +32.7% | 9,500 | +43.9% | 0.04% | +37.0% |
| Q3 2015 | $315,000 | – | 6,600 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 1,385,000 | $58,862,000 | 5.19% |
| SIGNIA CAPITAL MANAGEMENT LLC | 146,589 | $6,230,000 | 2.32% |
| HEARTLAND ADVISORS INC | 1,773,782 | $75,386,000 | 1.31% |
| NORTH TIDE CAPITAL, LLC | 350,000 | $14,875,000 | 1.30% |
| Aurora Investment Counsel | 38,196 | $1,623,000 | 1.07% |
| INVESTMENT COUNSELORS OF MARYLAND LLC | 571,150 | $24,274,000 | 0.99% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 102,500 | $4,356,000 | 0.90% |
| Tributary Capital Management, LLC | 98,862 | $4,202,000 | 0.83% |
| PERKINS CAPITAL MANAGEMENT INC | 27,850 | $1,184,000 | 0.80% |
| Iguana Healthcare Management, LLC | 25,000 | $1,063,000 | 0.61% |